131
Participants
Start Date
August 31, 2009
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
ranibizumab (Lucentis(R))
0.5 mg intravitreal injection once a month for 4 months, then as needed for 2 months
University of California, Davis, Sacramento
Collaborators (1)
Genentech, Inc.
INDUSTRY
Lawrence S. Morse, MD
OTHER